A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-Cell production and immunotherapy response in metastatic breast cancer Meeting Abstract
| Authors: | Page, D.; Collins, K.; Chun, B.; Sun, Z.; Koguchi, Y.; Redmond, W.; Martel, M.; Wu, Y.; Moxon, N.; Mellinger, S.; Urba, W.; Gucalp, A.; Traina, T. |
| Abstract Title: | A phase II study of nivolumab, ipilimumab, plus androgen receptor blockade with bicalutamide to enhance thymic T-Cell production and immunotherapy response in metastatic breast cancer |
| Meeting Title: | 36th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2021) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 9 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2021 Nov 10-14 |
| Meeting Location: | Washington, DC |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2021-11-01 |
| Start Page: | A431 |
| Language: | English |
| ACCESSION: | WOS:000774877500386 |
| DOI: | 10.1136/jitc-2021-SITC2021.399 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 399 -- Meeting was also presented virtually -- Source: Wos |
